Bill

Bill > H941


MA H941

MA H941
Relative to the care and treatment of patients with mitochondrial disease


summary

Introduced
01/20/2015
In Committee
01/20/2015
Crossed Over
Passed
Dead
07/31/2016

Introduced Session

189th General Court

Bill Summary

Relative to insurance coverage and payment for prescribed treatment for mitochondrial disease. Financial Services.

AI Summary

This bill mandates that various insurance policies and plans in the Commonwealth must cover treatments for mitochondrial disease, a group of genetic disorders affecting energy production in cells. Specifically, it requires the Group Insurance Commission to provide coverage for active or retired state employees and their families, and it also mandates that any insurance policy, contract, agreement, plan, or certificate of insurance, including hospital service plans and medical service agreements, issued or renewed within the Commonwealth must cover these treatments. The bill clarifies that "treatment" includes the use of vitamin and nutritional supplements such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1, and L-Carnitine.

Committee Categories

Business and Industry

Sponsors (23)

Last Action

Accompanied a new draft, see H4205 (on 04/13/2016)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...